Roche announced that Pascal Soriot will be taking over as head of the company's pharma division when Bill Burns steps down at the end of the year, according to the Wall Street Journal's Health Blog. According to Roche, Soriot joined the company from Sanofi-Aventis and oversaw the Genentech integration. The Health Blog says Soriot "has big shoes to fill. Burns led a long period of growth at the pharma division, and has been a favorite with analysts and investors, who say they appreciate his straightforward manner and wit."
Sep 09, 2009